Stock ownership · SEC 13F · Q3 2025
AKEBIA THERAPEUTICS INC
Institutional ownership of AKEBIA THERAPEUTICS INC (CUSIP 00972D105) - who holds it, how concentrated it is, and what moved last quarter.
- $497K
- Reported value
- 2
- Institutions
- 100%
- Top-5 share
The verdict
2 institutions report $497K of AKEBIA THERAPEUTICS INC positions as of Q3 2025, with ownership heavily concentrated in a handful of holders.
- 2
- institutions hold it
- $497K
- reported 13F value
- 100%
- held by top 5
Based on long positions reported to the SEC as of Q3 2025; 13F omits shorts, options and non-US holdings.
How 13F ownership is computed · All tracked stocks · Concentration rankings
SEC Form 13F-HR ownership desk
CUSIP 00972D105 · Q3 2025 $0M reported
VALUE-TRACE · HOLDERS-FOCUS · CONC-DOM · PHOTO-UNK · ACTIVITY-LIGHT · BOOK-MID
- VALUE-TRACE $0.5M
- HOLDERS-FOCUS 2 filers
- CONC-DOM 100% top-5
- PHOTO-UNK No peer
- ACTIVITY-LIGHT 2 new
- BOOK-MID 5Q history
Read with: Ownership concentration guide - AKEBIA THERAPEUTICS INC's top-five holders account for 100% of reported value — read concentration before treating any single filer as a signal.
Institutional ownership over time
The number of institutions reporting a AKEBIA THERAPEUTICS INC position has risen from 1 to 2 over the last 5 quarters of 13F filings.
Top Institutional Holders
| # | Institution | Shares | Value | Share of reported |
|---|---|---|---|---|
| 1 | JPMORGAN CHASE & CO (JPM, AMJB, VYLD, JPM-PC, JPM-PD, JPM-PJ, JPM-PK, JPM-PL, JPM-PM) | 155,377 | $424K | 85.4% |
| 2 | CIBC Bancorp USA Inc. | 26,650 | $73K | 14.6% |
Investment Discretion
SEC Form 13F requires each institutional filer to report whether it exercises sole or shared discretion over a position. Among AKEBIA THERAPEUTICS INC's reported holders for Q3 2025, by reported value:
Latest Quarter Activity · Q3 2025
New positions (2)
Complete exits (1)
Frequently Asked Questions
How many institutions hold AKEBIA THERAPEUTICS INC?▼
What is the total institutional value of AKEBIA THERAPEUTICS INC?▼
How concentrated is ownership of AKEBIA THERAPEUTICS INC?▼
Who is the largest institutional holder of AKEBIA THERAPEUTICS INC?▼
Source: U.S. Securities and Exchange Commission (SEC) - EDGAR Form 13F-HR institutional holdings filings · Q3 2025 13F-HR discloses long US-listed equity positions of managers with $100M+ qualifying assets, filed within 45 days of period end. Short positions and most derivatives are not disclosed.
PlainFundData is rendered directly from SEC EDGAR Form 13F-HR institutional holdings filings, no number is typed in by an editor. Holder lists, concentration, and reported value on this page are aggregated live from those 13F-HR extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-16.